Pertuzumab, trastuzumab, and standard anthracycline- and taxane-based chemotherapy for the neoadjuvant treatment of patients with HER2-positive localized breast cancer (BERENICE): a phase II, open-label, multicenter, multinational cardiac safety study
Titel:
Pertuzumab, trastuzumab, and standard anthracycline- and taxane-based chemotherapy for the neoadjuvant treatment of patients with HER2-positive localized breast cancer (BERENICE): a phase II, open-label, multicenter, multinational cardiac safety study
Auteur:
Swain, S.M. Ewer, M.S. Viale, G. Delaloge, S. Ferrero, J.-M. Verrill, M. Colomer, R. Vieira, C. Werner, T.L. Douthwaite, H. Bradley, D. Waldron-Lynch, M. Kiermaier, A. Eng-Wong, J. Dang, C.